8/10/2012 8:16:03 AM
Activist investor Carl Icahn, engaged in a bitter proxy battle with Forest Laboratories Inc, accused the drugmaker of hiding information from shareholders that might show it has built provisions into its licensing agreements that would deter a potential suitor. Icahn said on Friday he had asked a Delaware court to allow him to release non-public information to shareholders that he believes would shed light on the matter. Forest has refused to release documents that would answer the question, but a court agreed recently to allow Icahn to see them.
comments powered by